Gene Expression Profile and Inflammation Profile of Classic Asthma, Cough Variant Asthma and Eosinophilic Bronchitis

NCT02555345 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2015-09-21

No results posted yet for this study

Summary

This study aims to identify and validate the gene expression differentials of peripheral blood mononuclear cells and differential inflammation profiles and other aspects in classic asthma, cough-variant asthma and eosinophilic bronchitis.

Conditions

  • Asthmatic Bronchitis

Sponsors & Collaborators

  • State Key Laboratory of Respiratory Disease

    lead OTHER

Principal Investigators

  • Kefang Lai, PHD · The First Affiliated Hospital of Guangzhou Medical University

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2016-01-31
Completion
2016-01-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02555345 on ClinicalTrials.gov